Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Meatpacker JBS invests $100 million in cellular meat company

by Matt Blois
November 26, 2021 | A version of this story appeared in Volume 99, Issue 43

JBS, which calls itself the world’s largest protein company, is taking a majority stake in the Spanish cell-based meat firm BioTech Foods. The $100 million investment will include a plant in Spain and a research center in Brazil, where JBS is based. JBS expects the Spanish plant to reach commercial production by 2024 and plans to eventually add a plant at the R&D center. While this is JBS’s first foray into cultivated meat, which is grown from animal cells, competitors Tyson and Cargill have made similar investments.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.